 "German investor Paragon Partners buys Balda AG for Euro 62.9 mn")
Paragon Partners, a private investment company, has acquired Balda AG - a provider of high-end plastics solutions for sophisticated applications in the healthcare, lifestyle, automotive and consumer electronics industries – for Euro 62.9 million. The sale comprises all operational units of the Balda Group, ie Balda Medical GmbH & Co KG, Bad Oeynhausen, Balda C Brewer Inc and Balda Precision Inc (both in California, USA) as well as Balda Medical Systems SRL, Romania and further assets.
"Within the scope of our dialog with investors and possible cooperation partners, we have noticed increasing interest in our operational units. This resulted in specific negotiations, which, ultimately culminated in the agreement. The purchase offer by Paragon Partners did not only exceed the fair value calculated by external experts but will also give Balda the opportunity to continue to develop as an individual company,” said Oliver Oechsle, sole Management Board member of Balda AG.
Paragon Partners is aiming to sustainably improve the strategic and operating business of its shareholdings. Paragons founding partner Krischan von Moeller added, “Under the successful management team, the Balda Group will continue as an operational unit in accordance with today's strategic orientation. We will support Balda to actively make use of growth opportunities in the areas of medical technology as well as pharmaceutical and, if needed, may provide further equity for organic and external growth."
Oliver Oechsle said, "By selling the operating business of the Balda Group, we are creating a significant increase in value for the shareholders. Paragon Partners has confirmed that it will maintain the current strategic orientation and organisational structure and that it will retain all employees of Balda AG as well as the management. This means stability and continuity. Balda pursues the goal of continuing to further develop over the next few years - both organically and strategically so as to achieve an order of magnitude that will offer us completely new courses of action."
"Within the scope of our dialog with investors and possible cooperation partners, we have noticed increasing interest in our operational units. This resulted in specific negotiations, which, ultimately culminated in the agreement. The purchase offer by Paragon Partners did not only exceed the fair value calculated by external experts but will also give Balda the opportunity to continue to develop as an individual company,” said Oliver Oechsle, sole Management Board member of Balda AG.
Paragon Partners is aiming to sustainably improve the strategic and operating business of its shareholdings. Paragons founding partner Krischan von Moeller added, “Under the successful management team, the Balda Group will continue as an operational unit in accordance with today's strategic orientation. We will support Balda to actively make use of growth opportunities in the areas of medical technology as well as pharmaceutical and, if needed, may provide further equity for organic and external growth."
Oliver Oechsle said, "By selling the operating business of the Balda Group, we are creating a significant increase in value for the shareholders. Paragon Partners has confirmed that it will maintain the current strategic orientation and organisational structure and that it will retain all employees of Balda AG as well as the management. This means stability and continuity. Balda pursues the goal of continuing to further develop over the next few years - both organically and strategically so as to achieve an order of magnitude that will offer us completely new courses of action."